OTC: BDUUF - Bangkok Dusit Medical Services Public Company Limited

Yield per half year: 0%
Sector: Healthcare

Bangkok Dusit Medical Services Public Company Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
28.7 31.92 -10.1% 12.54 +128.88%
P/S 4.09 3.26 25.41%
P/BV 0.1214 3.36 -96.39%
P/FCF 0 21.19 -100%
Ev/Ebitda 30.71 10.07 204.86%
Ev/S 7.62 1.92 297.91%
Ev/FCF 1.79 20.49 -91.26%
E/P 0 1.47 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.82 24.35 1.96% 26.34 -5.75%
ROE 0.4391 13.19 -96.67%
ROA 0.2913 6.14 -95.25%
ROIC 0 15.56 -100%
ROS 14.27 12.56 13.62%
ROCE 0.5636 14.36 -96.07%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
14.87 6.21 139.4% 11.35 +30.98%
Nеt Debt/Ebitda 14.21 -5.72 -348.34%
Debt/Ratio 0.0753 0.2122 -64.5%
Debt/Equity 14.15 2.59 446.23%
Debt/Net Income 25.86 15.05 71.81%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
6.55/10
2.62 1.73 51.65% 2.72 -3.77%
Number of years of dividend growth 1 1.27 -21.11%
DSI 0.8571 0.7783 10.13%
Average dividend growth -138.99 -270.03 -48.53%
Average percentage for 5 years 2.72 2.79 -2.57%
Average percentage for payments 168.89 246.79 -31.56%
Difference from average difference in sector 0.8923

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-95.88 140.59 -168.2%
Growth impulse Ebitda in 5 years -96.82 107.17 -190.34%
Growth impulse Net Income in 5 years -96.87 123.16 -178.65%
Growth impulse FCF in 5 years 120.94 93.68 29.1%
Growth impulse EPS in 5 years -96.87 228.95 -142.31%
IP Score
3.67/10

Similar companies

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

Teligent, Inc.

Eisai Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription